Effect of abrupt discontinuation versus gradual dose reduction of postmenopausal hormone therapy on hot flushes

Climacteric

Volumn 13, Issue 4, 2010, Pages 362-367

  Cunha, E P ^a   Azevedo, L H ^a   Pompei, L M ^a   Strufaldi, R ^a   Steiner, M L ^a   Ferreira, J A S ^a   Peixoto, S ^a   Fernandes, C E ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Hormone therapy; Hot flushes; Low dose postmenopausal hormone therapy; Menopause; Treatment discontinuation

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; NORETHISTERONE ACETATE; PLACEBO; NORETHISTERONE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; COMPARATIVE STUDY; DRUG WITHDRAWAL; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; ANALOGS AND DERIVATIVES; CONTROLLED STUDY; ESTROGEN THERAPY; HOT FLASHES; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME;

ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; NORETHINDRONE; PLACEBOS; TIME FACTORS;

EID: 77953547321     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697130903568534     Document Type: Article

References (17)

1. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10:197-214
2. National Institutes of Health State-of-the-Science Conference Statement: Management of Menopause-Related Symptoms. Ann Intern Med 2005;142:1003-1013
3. Nelson HD. Menopause. Lancet 2008;371:760-770
4. Ettinger B, Grady D, Tosteson AN, et al. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-1232
5. Lazar F Jr, Costa-Paiva L, Morais SS, et al. The attitude of gynecologists in Sao Paulo, Brazil 3 years after the Women's Health Initiative study. Maturitas 2007;56: 129-141
6. Grady D, Sawaya GF. Discontinuation of postmenopausal hormone therapy. Am J Med 2005;118(Suppl 12B): 163-165
7. Haimov-Kochman R, Barak-Glantz E, Arbel R, et al. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study. Menopause 2006;13: 370-376
8. Aslan E, Bagis T, Kilicdag EB, et al. How best is to discontinue postmenopausal hormone therapy: immediate or tapered? Maturitas 2007;56:78-83
9. Blatt MH, Weisbader H, Kupperman HS. Vitamin E and climacteric syndrome. Arch Intern Med 1953;91:792-799
10. Ness J, Aronow WS, Beck G. Menopausal symptoms after cessation of hormone replacement therapy. Maturitas 2006;53:356-361
11. Ockene JK, Barad DH, Cochrane BB, et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005;294:183-193
12. Lindh-Åstrand L, Bixo M, Hirschberg AL, et al. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms. Menopause 2010;17:72-79
13. Haskell SG. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy. J Womens Health (Larchmt) 2004;13:438-442
14. Haskell SG, Bean-Mayberry B, Gordon K. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms. Menopause 2009;16:494-499
15. Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 2009;16:453-457
16. Palacios S, Ferrer-Barriendos J, Parrilla JJ, et al. [Healthrelated quality of life in the Spanish women through and beyond menopause. Development and validation of the Cervantes Scale]. Med Clin (Barc) 2004;122:205-211
17. Alder E. The Blatt-Kupperman menopausal index: a critique. Maturitas 1998;29:19-24